Stay updated on SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial

Sign up to get notified when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.3%
    Check dated 2024-09-04T06:23:25.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A new study has been added, now totaling 52 studies, with details about a recruiting site in Tampa, Florida, including contact information for the principal investigator.
    Difference
    0.7%
    Check dated 2024-08-21T01:33:43.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A new study has been added, increasing the total to 51, with details about recruitment at the Children's Hospital of Michigan, while the previous study has been removed, updating the revision from v2.10.0 to v2.10.2.
    Difference
    0.9%
    Check dated 2024-08-14T00:39:43.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    A new phase II trial has been added to evaluate the safety and efficacy of revumenib in combination with chemotherapy for infants and young children with relapsed or refractory KMT2A-rearranged leukemia, replacing the previous study that referred to SNDX-5613.
    Difference
    10%
    Check dated 2024-08-06T23:11:22.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2024-07-30T23:07:21.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2024-07-29T21:49:24.000Z thumbnail image

Stay in the know with updates to SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.